|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Verve Therapeutics (NASDAQ: VERV) through any online brokerage.
The latest price target for Verve Therapeutics (NASDAQ: VERV) was reported by William Blair on July 12, 2021. The analyst firm set a price target for 92.00 expecting VERV to rise to within 12 months (a possible 65.59% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Verve Therapeutics (NASDAQ: VERV) is $55.56 last updated Today at 8:00:01 PM.
There are no upcoming dividends for Verve Therapeutics.
There is no upcoming split for Verve Therapeutics.
Verve Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.